Chronic Pelvic Pain in Men Workup
- Author: Richard A Watson, MD; Chief Editor: Edward David Kim, MD, FACS more...
Approach Considerations
Because chronic pelvic pain syndrome (CPPS) is a diagnosis of exclusion, review the patient's records and perform a thorough physical examination to eliminate the possibility that another, more treatable disease is causing these symptoms. Assure the patient that only diagnostic tests that hold a reasonable chance of producing a significant result will be recommended. The patient should not rule out the possibility that these examinations may reveal an alternate diagnosis, but he should also know that he will not be burdened by excessive testing.
Excluding potentially fatal conditions (eg, prostate cancer, obstructive uropathy, pyonephrosis, bladder cancer, carcinoma in situ of the bladder) to any reasonably possible extent is imperative. Further, remember that patients with a documented, long-standing diagnosis of prostatodynia are not exempt from the development of any of these and other serious conditions.
Periodically, particularly in the setting of a flare-up of symptoms, a streamlined repetition of basic screening investigations, eg, thorough physical examination with digital rectal examination of the prostate, prostate-specific antigen (PSA) measurement, urine culture and cytology, renal and/or bladder ultrasonography, or intravenous pyelography, should be judiciously undertaken.
Imaging studies
Because no diagnostic finding for CPPS has proven definitive, all imaging studies (eg, kidney, ureter, and bladder radiography; intravenous pyelography; videocystourethrography; computed tomography [CT] scanning; magnetic resonance imaging [MRI]; ultrasonography of the scrotum; transrectal ultrasonography of the prostate) are aimed at excluding the presence of other, more definable and treatable causes of the patient's symptoms. None of these studies warrants universal application.
A cost-effective diagnostic algorithm should be individualized for each patient suspected of having CPPS, incorporating only laboratory tests and imaging procedures that are appropriate to that specific patient's problem.
Flow rate
A formal flow rate study often shows intermittency of flow and weakening of the urinary stream with a diminished peak urinary flow rate. The urethral pressure profile typically shows a high maximum urethral closing pressure.
Urinalysis and Culture
No tests exist for which the results unequivocally indicate the diagnosis of chronic pelvic pain syndrome (CPPS). The presence of pyuria, bacteriuria, or both supports a diagnosis of bacterial prostatitis.
The presence of an inordinate number of WBCs in the EPS and/or bacteria on Gram stain and/or a heavy, nearly pure growth of a known bacterial pathogen on culture indicate a diagnosis of bacterial prostatitis. However, contamination from the urethra, an external site, or a source of infection in the upper urinary tract can lead to a false-positive result, while errors in collection or processing can lead to a false-negative result.
The NIH Chronic Prostatitis Cohort Study, in reviewing the screening results from 488 men with chronic prostatitis (CP), CPPS, or both, found (discouragingly) no reliable correlation between the leukocyte counts or the bacterial counts and the degree of symptomatology, whether the analysis was performed on the EPS, the postmassage voided urine (ie, the third midstream bladder specimen [VB3]), or the ejaculate. The authors concluded that factors other than leukocytes and bacteria must contribute to symptom development in men with CPPS.[13]
Stamey recommended the 3-glass urinalysis method, and, while this approach is widely taught, it is much less widely practiced by clinical urologists today. Nickel suggested that a simplified premassage and postmassage test may prove more efficacious.[14]
Prostatic massage (diagnostic) and 3-glass urinalysis
Massaging the prostate produces EPS. The finding of high colony counts of bacterial pathogens and/or a significant excess of WBCs suggest the presence of a treatable infectious agent, particularly if these findings can be reproduced after a second massage. However, because eliminating urethral contaminants from these specimens is impractical, the clinical reliability of these findings is subject to challenge.
Most men find this process distinctly unpleasant, and many patients find the procedure greatly difficult or impossible to tolerate.
In many cases, no prostatic secretion flows from the meatus after massage. In these cases, Stamey recommends obtaining the first 10 mL of voided urine immediately following massage, a VB3, and submitting that specimen for Gram stain and culture as a substitute for the EPS.
Prostate-Specific Antigen Study
The PSA level is often elevated in men with acute bacterial prostatitis and may also be modestly elevated in those with chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS).
PSA testing in men with CPPS symptoms may be helpful in distinguishing between chronic bacterial prostatitis (ie, an elevated PSA value) and prostatodynia (ie, a PSA value within the reference range).[15] However, this theory has yet to be tested in a well-controlled clinical trial. Moreover, testing the theory presents problems because researchers would have to counsel large numbers of men who are younger than age 40 years and who have an elevated PSA value secondary to benign prostatic inflammation that their elevated PSA test result is not an indication of prostate cancer.
Urine Cytology
Voided urine cytologies, while not routine, should be readily considered whenever the index of suspicion is at all elevated, as it would be, for instance, in patients who have had a long history of smoking, who have had occupational exposure to known toxins, or who exhibit persistent microhematuria. When such a patient is undergoing cystoscopy, bladder-wash cytology should be obtained.
Carcinoma in situ, at times, presents as a velvety patch of mucosa, but often it may be indistinguishable from normal urothelium.
Videourodynamics
Videourodynamic evaluation often reveals evidence of a spastic dysfunction of the bladder neck and prostatic urethra. Beyond helping to detect occult neuropathies, urodynamic evaluation of patients with chronic pelvic pain syndrome (CPPS) type III may lead to a better understanding of the underlying voiding dysfunctions peculiar to select subsets of patients with this condition. Nickel contends that dysfunctional voiding and intraprostatic reflux of urine may be initiating factors in the onset of CPPS type III.[14]
Additionally, by subcategorizing patients with CPPS type III based on the presence and the nature of abnormal urodynamic findings, an improved rationale for case-specific therapies may be forthcoming.[16]
Incomplete relaxation of the bladder neck and abnormal narrowing of the prostatic urethra occur on voiding views.
These findings alone might not clearly justify the expense and discomfort associated with the procedure. The main role of urodynamic studies is to rule out another underlying, unsuspected, but well-defined neuropathy amenable to treatment.
Cystoscopy
Although the study results may be entirely normal, cystoscopy, at most, reveals only nonspecific findings of minimal to mild inflammation and congestion in the area of the trigone and prostatic urethra. The main purpose of this intervention is, as with uroradiography, to help rule out the presence of other causes of the patient's symptoms.
Cystoscopy can be performed in an outpatient setting after urethral injection of lidocaine (Xylocaine) jelly. However, cystoscopy under general or regional anesthesia or under conscious sedation offers a couple of advantages. As a rule, patients with chronic pelvic pain syndrome (CPPS) tend to be hypersensitive with a low pain tolerance. When the patient is unable to cooperate fully, endoscopic inspection is compromised.
In addition, general or regional anesthesia allows for more comfortable performance of cold-mucosal cup biopsies to rule out carcinoma in situ and for hydrodistention of the bladder to rule out interstitial cystitis. Also, minor pathology, such as an annular stricture of the urethra or a prostatic polyp, can be treated at the same time.
Anal Sphincter EMG and/or Sphincter Function Profiles
With anal sphincter electromyography (EMG) and/or sphincter function profiles (microtip catheter), the reflex reactivity during cystometrography is recorded, and findings indicate the presence of hypertonicity and failure of the pelvic floor musculature to relax. These are signs of an underlying myofascial pain syndrome. Overall pelvic floor activity during cystometrography can also be monitored via an intra-anal surface electrode.
While such experimental evaluations are not yet part of the standard urological armamentarium, they are available at select centers.[6]
Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. Sep 2004;172(3):839-45. [Medline].
Krieger JN, Riley DE. Chronic prostatitis: Charlottesville to Seattle. J Urol. Dec 2004;172(6 Pt 2):2557-60. [Medline].
Cohen RJ, Shannon BA, McNeal JE, Shannon T, Garrett KL. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?. J Urol. Jun 2005;173(6):1969-74. [Medline].
Rudick CN, Berry RE, Johnson JR, et al. Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun. Feb 2011;79(2):628-35. [Medline]. [Full Text].
Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol. Jan 2007;177(1):365-8. [Medline].
Zermann DH, Ishigooka M, Doggweiler R. Chronic Prostatitis: a myofascial syndrome?. Infect Urol. 1999;12:82-92.
Penna G, Fibbi B, Maggi M, Adorini L. Prostate autoimmunity: from experimental models to clinical counterparts. Expert Rev Clin Immunol. Sep 2009;5(5):577-86. [Medline].
Davis SN, Maykut CA, Binik YM, Amsel R, Carrier S. Tenderness as measured by pressure pain thresholds extends beyond the pelvis in chronic pelvic pain syndrome in men. J Sex Med. Jan 2011;8(1):232-9. [Medline].
Miller JL, Rothman I, Bavendam TG, Berger RE. Prostatodynia and interstitial cystitis: one and the same?. Urology. Apr 1995;45(4):587-90. [Medline].
Parsons CL, Albo M. Intravesical potassium sensitivity in patients with prostatitis. J Urol. Sep 2002;168(3):1054-7. [Medline].
Forrest JB, Schmidt S. Interstitial cystitis, chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men: a common and frequently identical clinical entity. J Urol. Dec 2004;172(6 Pt 2):2561-2. [Medline].
MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI, et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. J Urol. Sep 2006;176(3):1012-6. [Medline].
Schaeffer A, Stern J. Chronic prostatitis. Clin Evid. Jun 2002;(7):788-95. [Medline].
Nickel JC. Practical approach to the management of prostatitis. Tech Urol. Fall 1995;1(3):162-7. [Medline].
Pansadoro V, Emiliozzi P, Defidio L, Scarpone P, Sabatini G, Brisciani A, et al. Prostate-specific antigen and prostatitis in men under fifty. Eur Urol. 1996;30(1):24-7. [Medline].
Theodorou C, Konidaris D, Moutzouris G, Becopoulos T. The urodynamic profile of prostatodynia. BJU Int. Sep 1999;84(4):461-3. [Medline].
Davis BE, Weigel JW. Adenocarcinoma of the prostate discovered in 2 young patients following total prostatovesiculectomy for refractory prostatitis. J Urol. Sep 1990;144(3):744-5. [Medline].
Chung SD, Huang CC, Lin HC. Chronic prostatitis and depressive disorder: a three year population-based study. J Affect Disord. Nov 2011;134(1-3):404-9. [Medline].
Smart CJ, Jenkins JD, Lloyd RS. The painful prostate. Br J Urol. 1975;47(7):861-9. [Medline].
Anderson RU, Wise D, Sawyer T, Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol. Jul 2005;174(1):155-60. [Medline].
FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. Aug 2009;182(2):570-80. [Medline].
Wise D, Anderson RU. A Headache in The Pelvis: A New Understanding and Treatment. Occidental, CA: National Center for Pelvic Pain Research; 2003:[Full Text].
Anderson RU, Wise D, Sawyer T, Chan CA. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol. Oct 2006;176(4 Pt 1):1534-8; discussion 1538-9. [Medline].
Sadeghi-Nejad H, Seftel A. Sexual dysfunction and prostatitis. Curr Urol Rep. Nov 2006;7(6):479-84. [Medline].
Kaplan SA, Santarosa RP, D'Alisera PM, Fay BJ, Ikeguchi EF, Hendricks J, et al. Pseudodyssynergia (contraction of the external sphincter during voiding) misdiagnosed as chronic nonbacterial prostatitis and the role of biofeedback as a therapeutic option. J Urol. Jun 1997;157(6):2234-7. [Medline].
Lee SH, Lee BC. Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology. May 2009;73(5):1036-41. [Medline].
Anderson RU, Sawyer T, Wise D, Morey A, Nathanson BH. Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol. Dec 2009;182(6):2753-8. [Medline].
Meares EM Jr. Prostatitis. Med Clin North Am. Mar 1991;75(2):405-24. [Medline].
Meares EM Jr. Non-specific infections of the genitourinary tract. In: Tanagho EH, McAninch JW, eds. Smith's General Urology. 14th ed. Appleton & Lange: Norwalk, Conn; 1995:231-4.
Meares EM Jr. Prostatitis and related disorders. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbell's Urology. 7th ed. Philadelphia, Pa: WB Saunders; 1998:285-6.
Lee JC, Muller CH, Rothman I, Agnew KJ, Eschenbach D, Ciol MA, et al. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol. Feb 2003;169(2):584-7; discussion 587-8. [Medline].
Lowentritt JE, Kawahara K, Human LG, Hellstrom WJ, Domingue GJ. Bacterial infection in prostatodynia. J Urol. Oct 1995;154(4):1378-81. [Medline].
Taylor BC, Noorbaloochi S, McNaughton-Collins M, Saigal CS, Sohn MW, Pontari MA. Excessive antibiotic use in men with prostatitis. Am J Med. May 2008;121(5):444-9. [Medline].
Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol. Mar 1998;159(3):883-7. [Medline].
Berger R. Editorial comment: Urological survey--infection and inflammation in the genitourinary tract. J Urol. Jan 2009;181:135.
Pontari MA, Krieger JN, Litwin MS, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med. Sep 27 2010;170(17):1586-93. [Medline].
Schaeffer AJ. Editorial: Emerging concepts in the management of prostatitis/chronic pelvic pain syndrome. J Urol. Feb 2003;169(2):597-8. [Medline].

